Age at start of vaccine course

Vaccine type

Vaccine brand

Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease)

2–9 years

MenACWY

Preferably Menveo or Nimenrix, otherwise Menactra

1 dose

MenB

Bexsero

2 doses (8 weeks between doses)

≥10 years

MenACWYa

Preferably Menveo or Nimenrix, otherwise Menactra

1 dose

MenB

Bexsero

2 doses (8 weeks between doses)

MenB

Trumenba

2 doses (6 months between doses)

MenACWYa- a There is no registered upper age limit for use of Menveo and Nimenrix. Although Menactra is registered for use up to 55 years of age only, it can be given to people >55 years of age.

Last updated: 
5 June 2018
Last reviewed: 
5 June 2018